| Dr Amy Jane Byer, MD | |
|
121 Congressional Ln, Suite 316, Rockville, MD 20852-1542 | |
| (301) 468-6906 | |
| (301) 468-7639 |
| Full Name | Dr Amy Jane Byer |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 46 Years |
| Location | 121 Congressional Ln, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508915604 | NPI | - | NPPES |
| 7613 | Other | MD | CAREFIRST BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D22391 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elliot R Goldstein Md And Joel R Schulman Md Pa | 9335120278 | 44 |
News Archive
Various "telehealth" services - allowing consumers access to health care via telephone, Internet or other telecommunications devices - have cropped up in recent months, the Wall Street Journal reports.
The National Journal notes the two presidential candidates offer clear contrasts when it comes to their positions regarding health insurance. Meanwhile, Roll Call notes that the reported differences in opinions among the Supreme Court justices when they reviewed the health law continue to reverberate during this campaign season.
Debiopharm Group, the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology, today announced the start of a phase I, open label multicenter study of a selective FGFR 1, 2, 3 inhibitor, Debio 1347 (CH5183284) in patients with advanced solid tumors.
Computer algorithms were used in a recent study to identify the prevalence and incidence of epilepsy, and epilepsy-related mortality of patients in a managed care organization (MCO).
› Verified 9 days ago
| Entity Name | Elliot R Goldstein Md & Joel R Schulman Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164488300 PECOS PAC ID: 9335120278 Enrollment ID: O20040526001643 |
News Archive
Various "telehealth" services - allowing consumers access to health care via telephone, Internet or other telecommunications devices - have cropped up in recent months, the Wall Street Journal reports.
The National Journal notes the two presidential candidates offer clear contrasts when it comes to their positions regarding health insurance. Meanwhile, Roll Call notes that the reported differences in opinions among the Supreme Court justices when they reviewed the health law continue to reverberate during this campaign season.
Debiopharm Group, the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology, today announced the start of a phase I, open label multicenter study of a selective FGFR 1, 2, 3 inhibitor, Debio 1347 (CH5183284) in patients with advanced solid tumors.
Computer algorithms were used in a recent study to identify the prevalence and incidence of epilepsy, and epilepsy-related mortality of patients in a managed care organization (MCO).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Jane Byer, MD 121 Congressional Ln, Suite 316, Rockville, MD 20852-1542 Ph: (301) 468-6906 | Dr Amy Jane Byer, MD 121 Congressional Ln, Suite 316, Rockville, MD 20852-1542 Ph: (301) 468-6906 |
News Archive
Various "telehealth" services - allowing consumers access to health care via telephone, Internet or other telecommunications devices - have cropped up in recent months, the Wall Street Journal reports.
The National Journal notes the two presidential candidates offer clear contrasts when it comes to their positions regarding health insurance. Meanwhile, Roll Call notes that the reported differences in opinions among the Supreme Court justices when they reviewed the health law continue to reverberate during this campaign season.
Debiopharm Group, the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology, today announced the start of a phase I, open label multicenter study of a selective FGFR 1, 2, 3 inhibitor, Debio 1347 (CH5183284) in patients with advanced solid tumors.
Computer algorithms were used in a recent study to identify the prevalence and incidence of epilepsy, and epilepsy-related mortality of patients in a managed care organization (MCO).
› Verified 9 days ago
Thu Ngoc Tran, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9420 Key West Ave Ste 415, Rockville, MD 20850 Phone: 301-279-9400 Fax: 301-309-2428 | |
Dr. Mechele Silva, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2101 E Jefferson St, Rockville, MD 20852 Phone: 301-816-7405 | |
Stephen Andrew Lakner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9420 Key West Ave, Ste 415, Rockville, MD 20850 Phone: 301-279-9400 Fax: 301-279-0406 | |
Shivani Agarwal, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9711 Medical Center Dr Ste 109, Rockville, MD 20850 Phone: 301-762-5501 | |
Dorothy Chiu Lee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9420 Key West Ave, Ste 415, Rockville, MD 20850 Phone: 301-279-9400 Fax: 301-279-0313 | |
Jeanne E O'brien, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 15001 Shady Grove Rd, Suite 400, Rockville, MD 20850 Phone: 301-340-1188 Fax: 301-340-1612 | |
Emily Eckerley Lesch, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9711 Medical Center Dr, Suite 109, Rockville, MD 20850 Phone: 301-762-5501 Fax: 301-309-8727 |